Analyst Ratings for Avadel Pharmaceuticals (AVDL)
AVDL Rating Summary
AVDL Price Target Summary
- Highest: $22.50 (Wells Fargo)
- Lowest: $18.50 (Piper Sandler)
- Average: $19.93
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$19.93 (-7.9%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
Rating Score: 3.3 / 10
Percentile Rank: 30%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/28/2025 | UBS | Ashwani Verma | Downgrade | Neutral (Buy) |
20.00 (N/A) |
18.56 (21.64) |
16.59% | Details |
| 10/23/2025 | H.C. Wainwright | Oren Livnat | Downgrade | Neutral (Buy) |
20.00 (36.00) |
18.52 (21.64) |
16.85% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
